Wainzua
Active substance: eplontersen
eplontersen sodium
Centralised EU authorisationActive
Marketing holder: AstraZeneca AB
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-ac0d-73cd-8202-4b25da19bf65,01a1209b-8b58-72de-88de-fca7c7927729;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/006295
- Registration status
- Active
- ATC code
- N07XX21
Sources
- product · EMA · EMEA/H/C/006295 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006295 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006295 · Verified 2026-10-09